Market Expansion Opportunity argenx successfully launched Vyvgart in Italy, indicating readiness for global market penetration. This paves the way for further international expansion and entry into new territories.
Partnership Potential Collaborations with companies like FairJourney Biologics SA and Burnet Institute showcase argenx's openness to partnerships. Leveraging these alliances can lead to joint ventures and increased market presence.
Competitive Positioning Insight Being identified as a competitor to Biohaven Ltd. highlights argenx's strong standing in the autoimmune drugs market. Insights from competitive analysis can be utilized to enhance sales strategies and differentiate offerings.
Financial Strength Indicator Securing $1.1B in financing showcases argenx's financial stability and potential for large-scale investments. This capital can be allocated towards expanding sales operations and accelerating product commercialization.
Revenue Growth Opportunity With revenue in the range of $100M - 1B, argenx demonstrates significant market presence. This revenue range reflects the company's capacity for growth and indicates potential for increased sales volume and market share.
54K
$1B
60K$1B
102K$1B
2.6K$1B
103K$1B
10K$1B
87K$1B
11K$1B
51argenx uses 8 technology products and services including SAS, OneTrust, Microsoft Excel, and more. Explore argenx's tech stack below.
| argenx Email Formats | Percentage |
| FLast@argenx.com | 92% |
| FMiddleLast@argenx.com | 4% |
| Last_First@argenx.com | 2% |
| LastFirst@argenx.com | 2% |
Biotechnology ResearchMassachusetts, United States1001-5000 Employees
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
Company Overview
Funding & Financialsargenx has raised a total of $1.1B of funding over 10 rounds. Their latest funding round was raised on Jul 19, 2023 in the amount of $1.1B.
argenx's revenue is in the range of $100M$1B
Funding & Financialsargenx has raised a total of $1.1B of funding over 10 rounds. Their latest funding round was raised on Jul 19, 2023 in the amount of $1.1B.
argenx's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com